Suppr超能文献

[自制体外膜肺氧合系统治疗危重症患者的装机策略及临床观察]

[Installed strategy and clinical observation of self-made extracorporeal membrane oxygenation system in the treatment of critically ill patients].

作者信息

Chen Yue, Qian Xiaoliang, Dou Lidong, Li Jianchao

机构信息

Department of Anesthesia, People's Hospital of Henan Province (Fuwai Central China Cardiovascular Disease Hospital), Zhengzhou 450000, Henan, China.

Department of Extracorporeal Circulation, People's Hospital of Henan Province (Fuwai Central China Cardiovascular Disease Hospital), Zhengzhou 450000, Henan, China. Corresponding author: Dou Lidong, Email:

出版信息

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024 Apr;36(4):410-414. doi: 10.3760/cma.j.cn121430-20230914-00781.

Abstract

OBJECTIVE

To summarize the strategy and method for the treatment of critically ill patients with self-made extracorporeal membrane oxygenation (ECMO) system.

METHODS

A observative study was conducted. Fifty-six patients with ECMO assisted support in Fuwai Central China Cardiovascular Disease Hospital from December 2020 to December 2021 were enrolled. According to the clinical situation of the patients and the wishes of the family, conventional ECMO package (conventional group) or self-made ECMO package (self-made group) was chosen. In the conventional group, the disposable ECMO package was used to install the machine, pre charge and exhaust the air. In the self-made group, the disposable consumables commonly used in extracorporeal circulation during cardiac surgery (including centrifugal pump heads, membrane oxygenation, tubes, connectors, etc.) were used to create a self-made ECMO system. Based on the patient's situation, personalized tube model selection and length control were carried out. The preparation time, auxiliary time, auxiliary method, total pre charge volume, free hemoglobin (FHb) levels after 2 hours of ECMO operation and operating costs, as well as changes in hemodynamics, arterial blood gas analysis, and blood indicators within 48 hours after ECMO placement in the two groups were recorded. The occurrence of adverse events related to the ECMO system during ECMO adjuvant therapy in two groups was simultaneously observed.

RESULTS

Fifty-six patients were enrolled finally, with 28 cases in the conventional group and 28 cases in the self-made group, and all successfully completed the operation of ECMO. There was no statistically significant difference in ECMO system preparation time, auxiliary time, auxiliary method, and FHb levels after 2 hours of ECMO operation between the conventional group and the self-made group [preparation time (minutes): 13±4 vs. 15±5, auxiliary time (hours): 287±34 vs. 276±42, veno-arterial ECMO (cases): 22 vs. 24, veno-venous ECMO (cases): 6 vs. 4, FHb after 2 hours of ECMO operation (mg/L): 226±67 vs. 253±78, all P > 0.05]. However, the total pre charge volume and operating costs in the self-made group were significantly lower than those in the conventional group [total pre charge volume (mL): 420±25 vs. 650±10, operating costs (ten thousand yuan): 3.8±0.4 vs. 6.7±0.3, both P < 0.01]. The hemodynamics, arterial blood gas analysis, and blood indicators of patients in the two groups were relatively stable within 48 hours after ECMO operation, and most of the indicators between the two groups showed no statistically significant differences. The hemoglobin (Hb) levels at 12, 24, and 48 hours after the machine transfer in the self-made group were significantly higher than those in the conventional group (g/L: 128.5±23.7 vs. 117.5±24.3 at 12 hours, 121.3±31.3 vs. 109.6±33.2 at 24 hours, 118.5±20.1 vs. 105.2±25.7 at 48 hours, all P < 0.05). Both groups of patients did not experience any adverse event related to the ECMO system, such as membrane pulmonary infiltration, joint detachment, and massive hemolysis, during the ECMO assisted treatment process.

CONCLUSIONS

When implementing ECMO for critically ill patients in clinical practice, a self-made ECMO system with disposable consumables commonly used in extracorporeal circulation during cardiac surgery can be used for cardiopulmonary function assistance support, thereby saving patients medical costs and alleviating their dependence on disposable ECMO package in clinical practice.

摘要

目的

总结应用自制体外膜肺氧合(ECMO)系统治疗危重症患者的策略与方法。

方法

进行一项观察性研究。纳入2020年12月至2021年12月在阜外华中心血管病医院接受ECMO辅助支持的56例患者。根据患者临床情况及家属意愿,选择传统ECMO套装(传统组)或自制ECMO套装(自制组)。传统组使用一次性ECMO套装安装机器、预充及排气。自制组使用心脏手术体外循环常用的一次性耗材(包括离心泵头、膜肺、管道、接头等)制作自制ECMO系统。根据患者情况进行个性化管道型号选择及长度控制。记录两组患者的准备时间、辅助时间、辅助方式、总预充量、ECMO运行2小时后的游离血红蛋白(FHb)水平及运行成本,以及ECMO置管后48小时内血流动力学、动脉血气分析及血液指标的变化。同时观察两组患者在ECMO辅助治疗期间与ECMO系统相关不良事件的发生情况。

结果

最终纳入56例患者,传统组28例,自制组28例,均成功完成ECMO治疗。传统组与自制组在ECMO系统准备时间、辅助时间、辅助方式及ECMO运行2小时后的FHb水平方面差异无统计学意义[准备时间(分钟):13±4 vs. 15±5,辅助时间(小时):287±34 vs. 276±42,静脉 - 动脉ECMO(例数):22 vs. 24,静脉 - 静脉ECMO(例数):6 vs. 4,ECMO运行2小时后的FHb(mg/L):226±67 vs. 253±78,均P>0.05]。然而,自制组的总预充量及运行成本显著低于传统组[总预充量(mL):420±25 vs. 650±10,运行成本(万元):3.8±0.4 vs. 6.7±0.3,均P<0.01]。两组患者在ECMO运行后48小时内血流动力学、动脉血气分析及血液指标相对稳定,两组间多数指标差异无统计学意义。自制组在转机后12、24及48小时的血红蛋白(Hb)水平显著高于传统组(g/L:12小时时128.5±23.7 vs. 117.5±24.3,24小时时121.3±31.3 vs. 109.6±33.2,48小时时118.5±20.1 vs. 105.2±25.7,均P<0.05)。两组患者在ECMO辅助治疗过程中均未发生与ECMO系统相关的不良事件,如膜肺浸润、接头脱落及大量溶血等。

结论

在临床对危重症患者实施ECMO时,可采用心脏手术体外循环常用的一次性耗材制作自制ECMO系统用于心肺功能辅助支持,从而节省患者医疗费用,减轻临床对一次性ECMO套装的依赖。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验